Eli Lilly Pays $18M To Settle Contract Squabble
Eli Lilly & Co. has agreed to pay $18 million to settle a biotechnology company's claims that the pharmaceutical giant stole technology which converts injectable-only drugs into pills that can be...To view the full article, register now.
Already a subscriber? Click here to view full article